Recent Updates
Recently added Catalysts

Sofinnova Investments, Inc.

Track Sofinnova Investments, Inc.'s latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Jun 21, 2026
Showing 6 Stocks Out Of 67. Click On The Tickers For More Details
Stock Compnay Name Shares Held Market Value % of Portfolio QoQ Change
SYK
SYK
Stryker Corporation
44.48 K
14.62 M
0.6
TYRA
TYRA
Tyra Biosciences Inc
204.01 K
7.81 M
0.3
TNGX
TNGX
Tango Therapeutics Inc
395.08 K
8.27 M
0.3
ORIC
ORIC
Oric Pharmaceuticals Inc
679.58 K
8.61 M
0.3
EXEL
EXEL
Exelixis Inc
251.50 K
10.79 M
0.4
CMPX
CMPX
Compass Therapeutics Inc
2.06 M
10.88 M
0.4
API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $24.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Market Value

$ 2.63 B

Holdings

67

Period

Q1 2026

Holdings in Top 20

69.9 %

QoQ Changes

13.26 %

Top 20 Holdings